Loading company…
Riskpilot
← Back to search
Sign in
Get full access
CellCap Solutions ApS
APS
Active
CVR 43916882
Knudsvej 1
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2023
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -208K
+77% vs 2023
EBITDA margin
100.0%
-77% vs 2023
Equity ratio
-134.3%
Financial strength
Net profit 2024
DKK -208K
-75% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK -208K
+77%
EBITDA
DKK -208K
-77%
Net profit
DKK -208K
-75%
Total assets
DKK 214K
+2819%
Equity
DKK -288K
-263%
Employees
—
—
Company information
Legal name
CellCap Solutions ApS
CVR number
43916882
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14. marts 2023
Share capital
DKK 40.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør.
Company purpose
Selskabets formål er udvikling og salg af Medical Device og andet efter ledelsens skøn beslægtet virksomhed.
Contact
Address
Knudsvej 1
Phone
+4520275000
Email
jacob@cellcap.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Høje-Taastrup
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
DKK thousands
Item
2023
2024
Revenue
-117
-208
Staff expenses
-0
-0
EBITDA
-117
-208
Depreciation & amort.
-0
-0
EBIT
-117
-208
Net financials
-2
-0
Profit before tax
-119
-208
Tax
-0
-0
Net profit
-119
-208
Balance sheet
DKK thousands
Item
2023
2024
Total assets
7
214
Equity
-79
-288
Long-term debt
0
0
Short-term debt
87
502
Total debt
87
502
Financial ratios
5-year trend
EBITDA margin
-20807400.0%
This company
15.8%
Market median
-131692505% vs market
2023
2024
Equity ratio
-134.3%
This company
38.2%
Market median
-452% vs market
2023
2024
Return on equity
-20841200.0%
This company
18.4%
Market median
-113267491% vs market
2023
2024
Net profit margin
-20841200.0%
This company
8.1%
Market median
-257298865% vs market
2023
2024
Asset turnover
-0.97×
This company
1.12×
Market median
-187% vs market
2023
2024
Debt / equity
1.74×
This company
0.62×
Market median
-181% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-03-14 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
JI
Jacob Ilskov
Management
Management
2023
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
P. Guldberg ApS
Company
50.0%
50.0%
2025
Dahl R&D ApS
Company
15.0%
15.0%
2023
ILSKOV HOLDING ApS
Company
15.0%
15.0%
2023
SCIENCE VENTURES DENMARK A/S
Company
10.0%
10.0%
2023
KS Privat Urologi ApS
Company
5.0%
5.0%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Syddansk Universitet (University of Southern Denmark)
SCIENCE VENTURES DENMARK A/S
CellCap Solutions ApS
(this company)
Board network connections
Board members of CellCap Solutions ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Jacob Ilskov
Management
0 companies